Development of a reservoir-type transdermal delivery system containing eucalyptus oil for tetramethylpyrazine

References

• Amnuaikit C, Ikeuchi I, Ogawara K, et al. (2005). Skin permeation of propranolol from polymeric film containing terpene enhancers for transdermal use. Int J Pharm, 289:167–78
   PubMed Web of Science ®Google Scholar
• Anjos JL, Neto DS, Alonso A. (2007). Effects of 1,8-cineole on the dynamics of lipids and proteins of stratum corneum. Int J Pharm, 345:81–7
   PubMedGoogle Scholar
• Babu RJ, Pandit JK. (2005). Effect of penetration enhancers on the release and skin permeation of bupranolol from reservoir-type transdermal delivery systems. Int J Pharm, 288:325–34
   PubMed Web of Science ®Google Scholar
• Cai W, Dong SN, Lou YQ. (1989). HPLC determination of tetramethylpyrazine in human serum and its pharmacokinetic parameters. Acta Pharm Sin, 24:881–6
   Google Scholar
• Cui Y, Li LZ, Gu J, et al. (2011). Investigation of microemulsion system for transdermal delivery of ligustrazine phosphate. Afr J Pharm Pharmaco, 5:1674–81
   Web of Science ®Google Scholar
• Das MK, Bhattacharya A, Ghosal SK. (2006). Effect of different terpene-containing essential oils on percutaneous absorption of trazodone hydrochloride through mouse epidermis. Drug Deliv, 13:425–31
   PubMed Web of Science ®Google Scholar
• Diez I, Colom H, Moreno J, et al. (1991). A comparative in vitro study of transdermal absorption of a series of calcium channel antagonists. J Pharm Sci, 80:931–4
   PubMed Web of Science ®Google Scholar
• Dou YZ, Teng H, Wang Q, et al. (2008). Preparation, in vitro release and percutaneous penetration of ligustrazine hydrochloride transdermal delivery system. Chin J Pharm, 39:745–9
   Google Scholar
• Feng J, Liu RY, Wu GZ, et al. (1996). Tetramethylpyrazine reduces cardiac-derived TXA(2) release in ischaemic arrest in isolated working rat heart. Med Sci Res, 24:121–2
   Google Scholar
• Gao S, Singh J. (1998). In vitro percutaneous absorption enhancement of a lipophilic drug tamoxifen by terpenes. J Control Release, 51:193–9
   PubMed Web of Science ®Google Scholar
• Guo SK, Chen KJ, Qian ZH, et al. (1983). Tetramethylpyrazine in the treatment of cardiovascular and cerebrovascular diseases. Planta Med, 47:89–91
   PubMed Web of Science ®Google Scholar
• Han HX, Ma YS, Cui LL, et al. (2011). Primarily exploration of the preparation of ligustrazine phosphate transdermal patches and the effect on permeation enhancing of volatile oil of Flos Magnoliae. Chin Pharm J, 46:1915–18
   Google Scholar
• Ho WK, Wen HL, Lee CM. (1989). Tetramethylpyrazine for treatment of experimentally induced stroke in Mongolian gerbils. Stroke, 20:96–9
   PubMed Web of Science ®Google Scholar
• Jain AK, Thomas NS, Panchagnula R. (2002). Transdermal drug delivery of imipramine hydrochloride. I. Effect of terpenes. J Control Release, 79:93–101
   PubMed Web of Science ®Google Scholar
• Li M, Handa S, Ikeda Y, et al. (2001). Specific inhibiting characteristics of tetramethylpyrazine, one of the active ingredients of the Chinese herbal medicine ‘Chuanxiong,’ on platelet thrombus formation under high shear rates. Thromb Res, 104:15–28
   PubMed Web of Science ®Google Scholar
• Liang CC, Hong CY, Chen CF, et al. (1999). Measurement and pharmacokinetic study of tetramethylpyrazine in rat blood and its regional brain tissue by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl, 724:303–9
   PubMed Web of Science ®Google Scholar
• Liu X, Liu H, Liu J, et al. (2011a). Preparation of a ligustrazine ethosome patch and its evaluation in vitro and in vivo. Int J Nanomed, 6:241–7
   PubMed Web of Science ®Google Scholar
• Liu X, Liu H, Zeng Z, et al. (2011b). Pharmacokinetics of ligustrazine ethosome patch in rats and anti-myocardial ischemia and anti-ischemic reperfusion injury effect. Int J Nanomed, 6:1391–8
   PubMed Web of Science ®Google Scholar
• Liu XQ, Lou YQ, Chen QT. (1991). The clinical pharmacokinetic studies of tetramethylpyrazine hydrochloride in normal volunteers and patients with acute cerebral ischemia disease. Chin J Clin Pharmacol, 7:32–6
   Google Scholar
• Narishetty ST, Panchagnula R. (2004). Transdermal delivery of zidovudine: effect of terpenes and their mechanism of action. J Control Release, 95:367–79
   PubMed Web of Science ®Google Scholar
• Narishetty ST, Panchagnula R. (2005). Effect of l-menthol and 1,8-cineole on phase behavior and molecular organization of SC lipids and skin permeation of zidovudine. J Control Release, 102:59–70
   PubMed Web of Science ®Google Scholar
• Ocak F, Agabeyoglu I. (1999). Development of a membrane-controlled transdermal therapeutic system containing isosorbide dinitrate. Int J Pharm, 180:177–83
   PubMed Web of Science ®Google Scholar
• O’Neill CT, Deasy PB. (1988). Development and evaluation using hairless mouse skin of a transdermal timolol product. Int J Pharm, 48:247–54
   Google Scholar
• Qi X, Ackermann C, Sun D, et al. (2002). The prediction of plasma and brain levels of 2,3,5,6-tetramethylpyrazine following transdermal application. AAPS PharmSci, 4:E46
   PubMedGoogle Scholar
• Qi X, Ackermann C, Sun D, et al. (2003a). Physicochemical characterization and percutaneous delivery of 2,3,5,6-tetramethylpyrazine. Int J Pharm, 253:177–83
   PubMedGoogle Scholar
• Qi X, Liu RR, Sun D, et al. (2003b). Convolution method to predict drug concentration profiles of 2,3,5,6-tetramethylpyrazine following transdermal application. Int J Pharm, 259:39–45
   PubMed Web of Science ®Google Scholar
• Qiu L, Wang Q, Zhang J, et al. (2006). Studies on inhibition of crystallization and in vitro percutaneous absorption of tetramethylpyrazine transdermal delivery system. Chin Pharm J, 41:1642–6
   Google Scholar
• Shen HX, Xu HN, Shen T, et al. (2006). Enhancing effect of eucalyptus oil on the penetration of tetramethylpyrazine through rat skin. Chin J Clin Pharm, 15:112–14
   Google Scholar
• Shen T, Xu HN, Ding GB. (2001). Variations of in vitro tetramethylpyrazine permeation through human skin of different body regions. J Fudan Unive (Med Sci), 28:354–5
   Google Scholar
• Sheu JR, Kan YC, Hung WC, et al. (1997). Mechanisms involved in the antiplatelet activity of tetramethylpyrazine in human platelets. Thromb Res, 88:259–70
   PubMed Web of Science ®Google Scholar
• Tsai TH, Liang C. (2001). Pharmacokinetics of tetramethylpyrazine in rat blood and brain using microdialysis. Int J Pharm, 216:61–6
   PubMedGoogle Scholar
• Weng WY, Xu HN. (1999). Study on transdermal permeability of tetramethylpyrazine. J Shanghai Med Univ, 26:336–41
   Google Scholar
• Weng WY, Xu HN, Li GX, et al. (1997). HPLC determination of tetramethylpyrazine in serum and the permeation fluid. J Shanghai Med Univ, 24:379–80
   Google Scholar
• Williams AC, Barry BW. (2004). Penetration enhancers. Adv Drug Deliv Rev, 56:603–18
   PubMed Web of Science ®Google Scholar
• Xu BL, Wang H, Xu WM. (2001). Enhancing effect of synthetic borneol on skin permeation of ligustrazine hydrochloride. Chin Traditional Patent Med, 23:864–7
   Google Scholar
• Zhang CF, Yang ZL, Luo JB. (2006a). Effects of d-limonene and l-limonene on transdermal absorption of ligustrazine hydrochloride. Acta Pharm Sin, 41:772–777
   Google Scholar
• Zhang CF, Yang ZL, Luo JB. (2006b). Effects of enantiomer and isomer permeation enhancers on transdermal delivery of ligustrazine hydrochloride. Pharm Dev Technol, 11:417–24
   PubMed Web of Science ®Google Scholar
• Zhang CF, Yang ZL, Luo JB, et al. (2007a). Effects of cinnamene enhancers on transdermal delivery of ligustrazine hydrochloride. Eur J Pharm Biopharm, 67:413–19
   PubMed Web of Science ®Google Scholar
• Zhang RT, Wang H, Chen L. (2007b). Uniform design method for optimizing proportion of transdermal penetration enhancers of ligustrazine hydrochloride. Chin Traditional Herbal Drugs, 38:50–2
   Google Scholar
• Zhang S, Lin HQ, Deng H. (2005). Preparation and in-vitro drug release of ligustrazine phosphate sustained-release patches. Drug Eval, 2:292–4
   Google Scholar
• Zhao JH, Ji L, Wang H, et al. (2011). Microemulsion-based novel transdermal delivery system of tetramethylpyrazine: preparation and evaluation in vitro and in vivo. Int J Nanomed, 6:1611–19
   PubMed Web of Science ®Google Scholar
• Zou LY, Hao XM, Zhang GQ, et al. (2001). Effect of tetramethyl pyrazine on L-type calcium channel in rat ventricular myocytes. Can J Physiol Pharmacol, 79:621–6
   PubMed Web of Science ®Google Scholar